Accession Number: | 0001209191-16-138764 |
Date: | 2016-08-24 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2016-08-24 | M | 6,500 | a | $36.30 | 274,725 | direct | ||
COMMON STOCK | 2016-08-24 | S | 1,100 | d | $96.73 | 273,625 | direct | ||
COMMON STOCK | 2016-08-24 | S | 1,000 | d | $98.74 | 272,625 | direct | ||
COMMON STOCK | 2016-08-24 | S | 100 | d | $99.50 | 272,525 | direct | ||
COMMON STOCK | 2016-08-24 | S | 1,500 | d | $101.21 | 271,025 | direct | ||
COMMON STOCK | 2016-08-24 | S | 2,800 | d | $101.83 | 268,225 | direct | ||
COMMON STOCK | 2016-08-24 | S | 100 | d | $100.02 | 79,100 | indirect | ||
COMMON STOCK | 2016-08-24 | S | 900 | d | $101.60 | 78,200 | indirect | ||
COMMON STOCK | 2016-08-24 | 0 | $0.00 | 13,286 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 36.3 | 2016-08-24 | deemed execution date | M | 6,500 (d) | 2017-01-23 | common stock 6,500 | $36.30 | 131,500 | direct |
ID | footnote |
---|---|
f1 | transaction made pursuant to the holder's company approved trading plan under rule 10b5-1. |
f2 | the holder undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
f3 | open market sales reported on this line occurred at a weighted average price of $96.73 (range $96.40 to $97.37). |
f4 | open market sales reported on this line occurred at a weighted average price of $98.74 (range $98.37 to $99.19). |
f5 | open market sales reported on this line occurred at a weighted average price of $101.21 (range $100.63 to $101.60). |
f6 | open market sales reported on this line occurred at a weighted average price of $101.83 (range $101.63 to $102.45). |
f7 | open market sales reported on this line occurred at a weighted average price of $101.60 (range $101.25 to $102.00). |
f8 | fully vested. |